TrueWealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Sell |
1,556
-78
| -5% | -$14.5K | 0.09% | 177 |
|
|
2025
Q1 | $342K | Buy |
1,634
+67
| +4% | +$14K | 0.11% | 146 |
|
|
2024
Q4 | $279K | Buy |
1,567
+10
| +0.6% | +$1.78K | 0.09% | 178 |
|
|
2024
Q3 | $308K | Sell |
1,557
-43
| -3% | -$8.49K | 0.1% | 172 |
|
|
2024
Q2 | $274K | Buy |
1,600
+9
| +0.6% | +$1.54K | 0.1% | 178 |
|
|
2024
Q1 | $290K | Sell |
1,591
-28
| -2% | -$5.1K | 0.11% | 153 |
|
|
2023
Q4 | $251K | Buy |
1,619
+162
| +11% | +$25.1K | 0.1% | 163 |
|
|
2023
Q3 | $217K | Buy |
+1,457
| New | +$217K | 0.09% | 177 |
|
|
2023
Q2 | – | Sell |
-1,426
| Closed | -$227K | – | 187 |
|
|
2023
Q1 | $227K | Sell |
1,426
-206
| -13% | -$32.8K | 0.1% | 169 |
|
|
2022
Q4 | $264K | Buy |
1,632
+4
| +0.2% | +$646 | 0.12% | 143 |
|
|
2022
Q3 | $219K | Buy |
1,628
+1
| +0.1% | +$135 | 0.1% | 149 |
|
|
2022
Q2 | $249K | Sell |
1,627
-93
| -5% | -$14.2K | 0.12% | 138 |
|
|
2022
Q1 | $233K | Hold |
1,720
| – | – | 0.1% | 158 |
|
|
2021
Q4 | $233K | Buy |
+1,720
| New | +$233K | 0.1% | 158 |
|